Literature DB >> 9861026

Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.

A Kushi1, H Sasai, H Koizumi, N Takeda, M Yokoyama, M Nakamura.   

Abstract

To elucidate the role of neuropeptide Y (NPY)-Y1 receptor (Y1-R) in food intake, energy expenditure, and other possible functions, we have generated Y1-R-deficient mice (Y1-R-/-) by gene targeting. Contrary to our hypothesis that the lack of NPY signaling via Y1-R would result in impaired feeding and weight loss, Y1-R-/- mice showed a moderate obesity and mild hyperinsulinemia without hyperphagia. Although there was some variation between males and females, typical characteristics of Y1-R-/- mice include: greater body weight (females more than males), an increase in the weight of white adipose tissue (WAT) (approximately 4-fold in females), an elevated basal level of plasma insulin (approximately 2-fold), impaired insulin secretion in response to glucose administration, and a significant changes in mitochondrial uncoupling protein (UCP) gene expression (up-regulation of UCP1 in brown adipose tissue and down-regulation of UCP2 in WAT). These results suggest either that the Y1-R in the hypothalamus is not a key molecule in the leptin/NPY pathway, which controls feeding behavior, or that its deficiency is compensated by other receptors, such as NPY-Y5 receptor. We believe that the mild obesity found in Y1-R-/- mice (especially females) was caused by the impaired control of insulin secretion and/or low energy expenditure, including the lowered expression of UCP2 in WAT. This model will be useful for studying the mechanism of mild obesity and abnormal insulin metabolism in noninsulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861026      PMCID: PMC28100          DOI: 10.1073/pnas.95.26.15659

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.

Authors:  Y Dumont; J C Martel; A Fournier; S St-Pierre; R Quirion
Journal:  Prog Neurobiol       Date:  1992       Impact factor: 11.685

Review 2.  Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?

Authors:  C Wahlestedt; D J Reis
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

3.  Full amino acid sequence of centrally administered NPY required for maximal food intake response.

Authors:  C L McLaughlin; J S Tou; G J Rogan; C A Baile
Journal:  Physiol Behav       Date:  1991-03

4.  Neuropeptide Y: intrapancreatic neuronal localization and effects on insulin secretion in the mouse.

Authors:  M Pettersson; B Ahrén; I Lundquist; G Böttcher; F Sundler
Journal:  Cell Tissue Res       Date:  1987-04       Impact factor: 5.249

Review 5.  Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes.

Authors:  S F Leibowitz
Journal:  Brain Res Bull       Date:  1991 Sep-Oct       Impact factor: 4.077

6.  Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists.

Authors:  S P Kalra; M G Dube; A Fournier; P S Kalra
Journal:  Physiol Behav       Date:  1991-07

7.  Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

Authors:  C Wahlestedt; E M Pich; G F Koob; F Yee; M Heilig
Journal:  Science       Date:  1993-01-22       Impact factor: 47.728

8.  Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression.

Authors:  A Jacobsson; U Stadler; M A Glotzer; L P Kozak
Journal:  J Biol Chem       Date:  1985-12-25       Impact factor: 5.157

9.  Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism.

Authors:  C J Billington; J E Briggs; M Grace; A S Levine
Journal:  Am J Physiol       Date:  1991-02

10.  Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats.

Authors:  M Egawa; H Yoshimatsu; G A Bray
Journal:  Am J Physiol       Date:  1991-02
View more
  41 in total

Review 1.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

2.  A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice.

Authors:  Akane Ishihara; Akio Kanatani; Satoshi Mashiko; Takeshi Tanaka; Masayasu Hidaka; Akira Gomori; Hisashi Iwaasa; Naomi Murai; Shin-ichiro Egashira; Takashi Murai; Yuko Mitobe; Hiroko Matsushita; Osamu Okamoto; Nagaaki Sato; Makoto Jitsuoka; Takahiro Fukuroda; Tomoyuki Ohe; Xiaoming Guan; Douglas J MacNeil; Lex H T Van der Ploeg; Masaru Nishikibe; Yasuyuki Ishii; Masaki Ihara; Takehiro Fukami
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

3.  Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs.

Authors:  Anne Lecklin; Ingrid Lundell; Suvi Salmela; Pekka T Männistö; Annette G Beck-Sickinger; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 4.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

Review 5.  To subjugate NPY is to improve the quality of life and live longer.

Authors:  Satya P Kalra; Pushpa S Kalra
Journal:  Peptides       Date:  2007-01-09       Impact factor: 3.750

Review 6.  Brain regulation of energy balance and body weight.

Authors:  Liangyou Rui
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

7.  Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype.

Authors:  Kazuhiko Takahashi; Hiroaki Suwa; Tomoo Ishikawa; Hidehito Kotani
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

8.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

9.  Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice.

Authors:  Amanda Sainsbury; Paul A Baldock; Christoph Schwarzer; Naohiko Ueno; Ronaldo F Enriquez; Michelle Couzens; Akio Inui; Herbert Herzog; Edith M Gardiner
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice.

Authors:  Shu Lin; Yan-Chuan Shi; Ernie Yulyaningsih; Aygul Aljanova; Lei Zhang; Laurence Macia; Amy D Nguyen; En-Ju Deborah Lin; Matthew J During; Herbert Herzog; Amanda Sainsbury
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.